Creo Medical Group PLC (BST:1RC)

Germany flag Germany · Delayed Price · Currency is EUR
0.135
0.00 (0.00%)
At close: Apr 28, 2026
28.57%
Market Cap 56.29M
Revenue (ttm) 5.37M
Net Income (ttm) 583.30K
Shares Out n/a
EPS (ttm) -0.00
PE Ratio 96.50
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.134
Previous Close 0.135
Day's Range 0.131 - 0.137
52-Week Range 0.105 - 0.210
Beta n/a
RSI 46.96
Earnings Date May 13, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needl... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2003
Employees 129
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol 1RC
Full Company Profile

Financial Performance

In 2024, Creo Medical Group's revenue was 4.00 million, a change of 0.00% compared to the previous year's 4.00 million. Losses were -28.70 million, 32.3% more than in 2023.

Financial numbers in GBP

News

There is no news available yet.